Stock solutions of Amoxicillin and clindamycin were prepared by dissolving 25 mg in 25 mL of 0.9% NaCl. Standards were prepared for Amoxicillin (blank, 1, 5, 12.5, 25, 50 and 100 mg/L) and clindamycin (blank, 1, 5, 10 and 15 mg/L) by adding stock solutions to EDTA plasma. The QCs were prepared in plasma at concentrations levels of 2.5 and 50 mg/L for Amoxicillin and 5 and 12 mg/L for clindamycin. The standard and QC samples were stored at −80°C until use.
Clindamycin
Clindamycin is a pharmaceutical product manufactured by Merck Group for use in laboratory settings. It is an antibiotic medication commonly used in research applications. The core function of Clindamycin is to inhibit bacterial protein synthesis, which can be utilized in various experimental procedures. No further details or interpretations are provided.
Lab products found in correlation
102 protocols using clindamycin
Amoxicillin and Clindamycin Quantification
Stock solutions of Amoxicillin and clindamycin were prepared by dissolving 25 mg in 25 mL of 0.9% NaCl. Standards were prepared for Amoxicillin (blank, 1, 5, 12.5, 25, 50 and 100 mg/L) and clindamycin (blank, 1, 5, 10 and 15 mg/L) by adding stock solutions to EDTA plasma. The QCs were prepared in plasma at concentrations levels of 2.5 and 50 mg/L for Amoxicillin and 5 and 12 mg/L for clindamycin. The standard and QC samples were stored at −80°C until use.
Antimicrobial Susceptibility of Group B Streptococcus
Antimicrobial Susceptibility of Gardnerella vaginalis
One-hundred microliters of the prepared bacterial suspension (106 CFU/mL) was added to different concentrations of metronidazole and clindamycin at 37°C. After 48 h, the bacterial growth was evaluated by taking an endpoint reading at OD595 with a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA). The minimum inhibitory concentration (MIC) for metronidazole and clindamycin was defined as the lowest antibiotic concentration yielding marked reduction in the growth or no growth at all. Under the same conditions, G. vaginalis ATCC®14018 was tested using the broth microdilution assay. The microbiological susceptibility and resistant breakpoints for metronidazole (<8 μg/mL and ≥32 μg/mL) and clindamycin (<2 μg/mL and ≥8 μg/mL), as defined by CLSI, were used for interpreting MIC results [21 ].
PEG and Clindamycin Intestinal Modulation
Antibiotic Combination Treatments in Mice
Antimicrobial Compounds Acquisition and Purification
Gut Microbiome Manipulation via Antibiotics
Antibiotic Resistance Profiling of Isolates
The antibiotic resistance profile of the isolates was determined by the Kirby-Bauer disk-diffusion method on Muller-Hinton agar (MHA) (Merck & Co., Kenilworth, NJ, USA) with 5% sheep's blood, and the results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.
12
The antimicrobial agents (Mast Group Ltd, Bootle, UK) tested in the present study included ampicillin (10 μg), vancomycin (30 μg), erythromycin (15 μg), clindamycin (2 μg), levofloxacin (5 μg), chloramphenicol (30 μg), cefepime (30 μg), and linezolid (30 μg).
Streptococcus pneumoniaeATCC 49619 was used for quality control of antibiotic susceptibility testing.
Antibiotic Resistance Profiling of Probiotic LAB
Anaerobic Bacterial Antibiotic Resistance
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!